NRC insider trading

Healthcare

NATIONAL RESEARCH CORP — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
333
Last 90 days
2
Buys / sells
1% / 75%
Market cap
$272.57M

About NATIONAL RESEARCH CORP

National Research Corporation provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company also offers marketing experience solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools through a multi-mode digital platform. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; employee experience solutions that give care teams information, tools and support needed to create engagement and open communication throughout the employee lifecycle; and consumer experience solutions which capture feedback across the healthcare journey, drive choice to build volume, and co-design experiences and services through community insights. Additionally, the company offers Huey AI, an AI engine for Human Understanding that serves as a healthcare experience management companion; and governance solutions for not-for-profit health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Company website: www.nrchealth.com

NRC insider activity at a glance

FilingIQ has scored 333 insider transactions for NRC since Jun 21, 2018. The most recent filing in our index is dated Mar 12, 2026.

Across the full history, 3 open-market purchases and 250 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NRC insider trades is 52.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for NRC?
FilingIQ tracks 333 Form 4 insider transactions for NRC (NATIONAL RESEARCH CORP), covering filings from Jun 21, 2018 onwards. 2 of those were filed in the last 90 days.
Are NRC insiders net buyers or net sellers?
Across the full Form 4 history for NRC, 3 transactions (1%) were open-market purchases and 250 (75%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NRC insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NRC in?
NATIONAL RESEARCH CORP (NRC) is classified in the Healthcare sector, specifically Health Information Services, with a current market capitalisation of $272.57M.

Methodology & sources

Every NRC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.